Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tyler E Miller

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Cancer Cell|October 14, 2015
Preferential Iron Trafficking Characterizes Glioblastoma Stem-like CellsDavid L Schonberg, Tyler E Miller, Qiulian Wu, et al.
Cell|January 7, 2021
COVID-19-neutralizing antibodies predict disease severity and survivalWilfredo F Garcia-Beltran, Evan C Lam, Michael G Astudillo, et al.
Medrxiv : the Preprint Server for Health Sciences|October 27, 2020
COVID-19 neutralizing antibodies predict disease severity and survivalWilfredo F Garcia-Beltran, Evan C Lam, Michael G Astudillo, et al.
Medrxiv : the Preprint Server for Health Sciences|February 10, 2021
Recruitment location influences bias and uncertainty in SARS-CoV-2 seroprevalence estimatesTyler S Brown, Pablo Martinez de Salazar Munoz, Abhishek Bhatia, et al.
Cell Stem Cell|December 20, 2016
Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug ToleranceBrian B Liau, Cem Sievers, Laura K Donohue, et al.
The Journal of Infectious Diseases|September 9, 2020
High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, MassachusettsVivek Naranbhai, Christina C Chang, Wilfredo F Garcia Beltran, et al.
Nature|April 22, 2015
Drug-based modulation of endogenous stem cells promotes functional remyelination in vivoFadi J Najm, Mayur Madhavan, Anita Zaremba, et al.
Cell|August 26, 2025
Transient gene melting governs the timing of oligodendrocyte maturationKevin C Allan, Jesse J Zhan, Andrew R Morton, et al.
Nature|July 6, 2017
Transcription elongation factors represent in vivo cancer dependencies in glioblastomaTyler E Miller, Brian B Liau, Lisa C Wallace, et al.
Virulence|May 19, 2022
Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19David J Gregory, Augustin Vannier, Akiro H Duey, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Cancer Cell|October 14, 2015
Preferential Iron Trafficking Characterizes Glioblastoma Stem-like CellsDavid L Schonberg, Tyler E Miller, Qiulian Wu, et al.
Cell|January 7, 2021
COVID-19-neutralizing antibodies predict disease severity and survivalWilfredo F Garcia-Beltran, Evan C Lam, Michael G Astudillo, et al.
Medrxiv : the Preprint Server for Health Sciences|October 27, 2020
COVID-19 neutralizing antibodies predict disease severity and survivalWilfredo F Garcia-Beltran, Evan C Lam, Michael G Astudillo, et al.
Medrxiv : the Preprint Server for Health Sciences|February 10, 2021
Recruitment location influences bias and uncertainty in SARS-CoV-2 seroprevalence estimatesTyler S Brown, Pablo Martinez de Salazar Munoz, Abhishek Bhatia, et al.
Cell Stem Cell|December 20, 2016
Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug ToleranceBrian B Liau, Cem Sievers, Laura K Donohue, et al.
The Journal of Infectious Diseases|September 9, 2020
High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, MassachusettsVivek Naranbhai, Christina C Chang, Wilfredo F Garcia Beltran, et al.
Nature|April 22, 2015
Drug-based modulation of endogenous stem cells promotes functional remyelination in vivoFadi J Najm, Mayur Madhavan, Anita Zaremba, et al.
Cell|August 26, 2025
Transient gene melting governs the timing of oligodendrocyte maturationKevin C Allan, Jesse J Zhan, Andrew R Morton, et al.
Nature|July 6, 2017
Transcription elongation factors represent in vivo cancer dependencies in glioblastomaTyler E Miller, Brian B Liau, Lisa C Wallace, et al.
Virulence|May 19, 2022
Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19David J Gregory, Augustin Vannier, Akiro H Duey, et al.
Pageof 6